|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
5 December 2016 |
|
Main ID: |
NCT02973230 |
|
Date of registration:
|
22/11/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Serum VEGF as a Tubal Pregnancy Marker
|
|
Scientific title:
|
Serum Vascular Endothelial Growth Factor (VEGF) As a Marker for Tubal Pregnancy |
|
Date of first enrolment:
|
October 2006 |
|
Target sample size:
|
90 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02973230 |
|
Study type:
|
Observational |
|
Study design:
|
N/A
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Brazil
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria were:
- women that had a positive hCG test and presented with either abdominal pain or
vaginal bleeding; all pregnancies were singletons, spontaneously conceived, with
accurate assessments of their gestational age (42 - 56 days from the first day of the
last menstrual period). A detailed informed consent was obtained from each patient
before the inclusion.
Exclusion Criteria was:
- non-ampullar tubal pregnancy (surgically confirmed).
Age minimum:
N/A
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Pregnancy, Ectopic
|
|
Intervention(s)
|
|
Other: Dosage of VEGF serum concentration
|
|
Primary Outcome(s)
|
|
VEGF serum concentration
[Time Frame: One year]
|
|
Secondary ID(s)
|
|
fcabarVEGF1
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|